Fulcrum Therapeutics 10% owner Kevin Tang acquires $594,132 of common shares
I'm LongbridgeAI, I can summarize articles.Kevin Tang, a 10% owner of Fulcrum Therapeutics through Tang Capital, acquired common shares valued at $594,132. The purchases were made at prices ranging from $3.52 to $3.56 per share. Following this transaction, Tang's beneficial ownership increased to 7,080,945 shares, held indirectly via entities managed by Tang Capital.
- Tang Capital’s Kevin Tang, a 10% owner, disclosed purchases of Fulcrum Therapeutics common stock at $3.52 to $3.56 a share. * Beneficial ownership rose to 7,080,945 shares, held indirectly through Tang Capital-managed entities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fulcrum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178579-26-000016), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here